Clarithromycin stops lung function decline in airway-centered interstitial fibrosis

Respiration

Volumn 85, Issue 2, 2013, Pages 156-159

  Jouneau, S ^a   Kerjouan, M ^a   Caulet Maugendre, S ^a   Guillot, S ^a   Meunier, C ^a   Desrues, B ^a   Delaval, P ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Anti inflammatory effect; Interstitial lung disease; Lung function decline; Macrolides; Pulmonary fibrosis

Indexed keywords

CLARITHROMYCIN; ESOMEPRAZOLE; PREDNISOLONE;

ABNORMAL RESPIRATORY SOUND; ADULT; AIRWAY CENTERED INTERSTITIAL FIBROSIS; AMBIENT AIR; ARTICLE; BRONCHIECTASIS; BRONCHIOLE; CASE REPORT; CAUCASIAN; CHRONIC BRONCHITIS; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; DRUG TREATMENT FAILURE; DYSPNEA; EOSINOPHIL; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG VOLUME; LYMPHOCYTE; MACROPHAGE; MALE; NEUTROPHIL; PREDICTIVE VALUE; PRIORITY JOURNAL; PULSE OXIMETRY; REST; SMOKING; TOTAL LUNG CAPACITY; ANTIINFLAMMATORY ACTIVITY; COMPUTER ASSISTED TOMOGRAPHY; CRACKLE; DETERIORATION; HYPERPLASIA; LUNG FUNCTION DETERIORATION; MAINTENANCE THERAPY; THORAX RADIOGRAPHY; TREATMENT DURATION;

ADULT; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; ENZYME INHIBITORS; ESOMEPRAZOLE SODIUM; GLUCOCORTICOIDS; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; PREDNISOLONE; PULMONARY FIBROSIS; RESPIRATORY FUNCTION TESTS; TREATMENT FAILURE;

EID: 84874107807     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000341982     Document Type: Article

References (10)

1. Churg A, Myers J, Suarez T, Gaxiola M, Estrada A, Mejia M, Selman M: Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease. Am J Surg Pat hol 2004; 28: 62-68.
2. Gaxiola M, Buendia-Roldan I, Mejia M, Carrillo G, Estrada A, Navarro MC, Rojas-Ser-rano J, Selman M: Morphologic diversity of chronic pigeon breeder's disease: clinical features and survival. Respir Med 2011; 105: 608-614.
3. Reghellin D, Poletti V, Tomassett S, Dubini A, Cavazza A, Rossi G, Lestani M, Pedron S, Daniele I, Montagna L, Murer B, Chilos M: Cathepsin-k is a sensitive immunohisto-chemical marker for detection of micro-granulomas in hypersensitivity pneumoni-tis. Sarcoidosis Vasc Diffuse Lung Dis 2010; 27:57-63.
4. Hara Y, Kobayashi H, Osoreda H, Kanoh S, Motoyoshi K, Ozeki Y: Bird-related chronic hypersensitivity pneumonitis demonstrating the f luctuation of disease activity accompanied with environmental changes. Nihon Kokyuki Gakkai Zasshi 2008; 46:1045-1049.
5. Yi XH, Chu HQ, Cheng XM, Luo BF, Li HP: Idiopathic airway-centered interstitial fibro-sis: report of two cases. Chin Med J (Engl) 2007; 120:847-850.
6. Fenton ME, Cockcroft DW, Wright JL, Churg A: Hypersensitivity pneumonitis as a cause of airway-centered interstitial fibrosis. Ann Allergy Asthma Immunol 2007; 99: 465-466.
7. Colombat M, Groussard O, Taille C, Mar-rash-Chahla R, Brugiere O, Mal H, Leseche G, Fournier M, Degott C: Lung transplantation in a patient with airway-centered fibro-sis. Am J Surg Pathol 2004; 28:1540-1542.
8. Serrano M, Molina-Molina M, Ramirez J, Sanchez M, Xaubet A: Airway-centered interstitial fibrosis related to exposure to fumes from cleaning products. Arch Bron-coneumol 2006; 42:557-559.
9. Altenburg J, de Graaff CS, van der Werf TS, Boersma WG: Immunomodulatory effects of macrolide antibiotics. 2. Advantages and disadvantages of long-term, low-dose mac-rolide therapy. Respiration 2011; 81: 75-87.
10. Altenburg J, de Graaff CS, van der Werf TS, Boersma WG: Immunomodulatory effects of macrolide antibiotics. 1. Biological mechanisms. Respiration 2011; 81: 67-74.